These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1409259)

  • 1. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
    Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
    Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.
    Leysen JE; Gommeren W; Janssen PA
    Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
    Dewar KM; Lima L; Reader TA
    Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].
    Fujishima Y; Hara H; Shimazawa M; Yokota K; Sukamoto T
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):19-29. PubMed ID: 8076888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
    Armstrong RA; Humphrey PP; Lumley P
    Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
    Vinge E; Andersson TL; Larsson B
    Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.
    Hoffmann D; Wesemann W
    J Neural Transm; 1985; 61(3-4):193-218. PubMed ID: 3157778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
    Tsuchihashi H; Yagi N; Kimura M; Shirota K; Kinami J; Nagatomo T
    J Pharmacobiodyn; 1991 Aug; 14(8):461-6. PubMed ID: 1663547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilized ketanserin binding sites from pig platelet membranes.
    Wesemann W; Hoffmann D
    Thromb Res; 1985 Sep; 39(6):693-700. PubMed ID: 2934860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 3H ketanserin binding in tension-type headache.
    Shukla R; Husain M; Tandon R; Khanna VK; Nag D; Dikshit M; Srimal RC; Seth PK
    Headache; 2003 Feb; 43(2):103-8. PubMed ID: 12558763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet 3H ketanserin binding in migraine.
    Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
    Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.
    Connor JD; Rasheed H; Gilani AH; Cheema M; Rizvi Z; Saeed SA
    Life Sci; 2001 Oct; 69(23):2759-64. PubMed ID: 11720080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F; David JL; Janssen PA
    Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
    Hashimoto K; Goromaru T
    Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors.
    Rego AC; Oliveira CR
    Neurochem Int; 1995 Dec; 27(6):489-96. PubMed ID: 8574178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.